USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2
Arun Pandian Chandrasekaran, Kamini Kaushal, Chang‐Hwan Park, Kye-Seong Kim, Suresh Ramakrishna
Abstract
, suggesting a novel way to treat tumors resistant to small-molecule drugs.
Topics & Concepts
Cancer cellCancerProteasesCancer researchDeubiquitinating enzymeBiologyIn vivoUbiquitinDrug resistanceChemistryGeneEnzymeBiochemistryGeneticsUbiquitin and proteasome pathwaysCancer-related Molecular PathwaysMicrotubule and mitosis dynamics